Published in Tissue Antigens on October 01, 2004
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy. Immunogenetics (2008) 1.03
Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors. Immunogenetics (2010) 1.03
Overexpression of beta2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion. Br J Cancer (2008) 0.99
A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis. Mol Cell Proteomics (2013) 0.81
Upregulation of β2-microglobulin expression in progressive human oral squamous cell carcinoma. Oncol Rep (2011) 0.75
An analysis of the interrelationship of the mixed odontogenic tumors--ameloblastic fibroma, ameloblastic fibro-odontoma, and the odontomas. Oral Surg Oral Med Oral Pathol (1981) 2.64
Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol (1984) 2.51
Gain-of-function mutations in the tumor suppressor gene p53. Clin Cancer Res (2000) 1.50
Myxoma of the jaws. An analysis of 15 cases. J Maxillofac Surg (1986) 1.47
Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol Biomarkers Prev (2000) 1.46
A case of cystic adventitial disease of the popliteal artery demonstrated by magnetic resonance imaging. J Vasc Surg (1993) 1.45
T-cell receptor V beta-family usage in primary cutaneous and primary nodal T-cell non-Hodgkin's lymphomas. J Invest Dermatol (1992) 1.43
Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest (1994) 1.23
Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens (2013) 1.22
Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol (1998) 1.17
Warthin's tumour and smoking. B-ENT (2005) 1.17
Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol (2006) 1.15
Osteosarcoma of the jaw bones. Analysis of 18 cases. J Maxillofac Surg (1985) 1.15
Current technologies for HER2 testing in breast cancer. Crit Rev Oncol Hematol (2011) 1.14
Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol (2001) 1.13
Extranodal non-Hodgkin's lymphoma of the oral tissues. An analysis of 20 cases. J Maxillofac Surg (1985) 1.13
Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia. Bone Marrow Transplant (2007) 1.10
Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma. Oral Oncol (2009) 1.10
Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood (1994) 1.06
Bio-energetic response of the heart to dopamine following brain death-related reduced myocardial workload: a phosphorus-31 magnetic resonance spectroscopy study in the cat. J Heart Lung Transplant (1999) 1.06
Glycosaminoglycans in myxoma of the jaw: a biochemical study. J Oral Pathol (1985) 1.06
Short tandem repeat markers in diagnostics: what's in a repeat? Leukemia (2006) 1.05
Leiomyosarcomas of the oral cavity. Report of four cases and review of the literature. J Craniomaxillofac Surg (1993) 1.05
The ameloblastoma, the controversial approach to therapy. J Maxillofac Surg (1985) 1.04
Condylar hyperplasia. A clinico-pathological analysis of 22 cases. J Maxillofac Surg (1986) 1.03
Endotoxin-induced inflammation and injury of the guinea pig respiratory airways cause bronchial hyporeactivity. Am Rev Respir Dis (1988) 1.02
Chromosomal instability predicts metastatic disease in patients with insulinomas. Endocr Relat Cancer (2005) 1.02
A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5. Tissue Antigens (2004) 1.02
Identification and in situ localization of the "thymic nurse cell" in man. J Immunol (1983) 1.01
Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders. J Oral Pathol Med (1998) 1.01
Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test. J Clin Microbiol (1992) 1.01
Histologic changes after vertebroplasty. J Bone Joint Surg Am (2004) 1.01
Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation. Leukemia (2010) 1.00
The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma. J Craniomaxillofac Surg (1991) 0.98
Multinucleate giant cells in sublabial salivary gland tissue in Sjögren's syndrome. A diagnostic pitfall. Virchows Arch A Pathol Anat Histopathol (1984) 0.97
Verrucous hyperplasia or verrucous carcinoma. An analysis of 27 patients. J Maxillofac Surg (1983) 0.96
Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms. Mol Pathol (2001) 0.95
Morphometric study of histological changes in sublabial salivary glands due to aging process. J Clin Pathol (1986) 0.95
Interobserver and intraobserver variability in the histologic assessment of oral lichen planus. J Oral Pathol Med (1999) 0.95
Ghost cell odontogenic carcinoma. Int J Oral Maxillofac Surg (2006) 0.94
Evaluation of the VX2 rabbit auricle carcinoma as a model for head and neck cancer in humans. J Craniomaxillofac Surg (2000) 0.94
Osteochondroma of the mandibular condyle. A case report. Int J Oral Maxillofac Surg (1996) 0.93
Mandibular invasion by oral squamous cell carcinoma. Clinical aspects. J Craniomaxillofac Surg (1990) 0.93
Comparison of DRB sequence-based typing using different strategies. Tissue Antigens (1997) 0.93
Orbital exenteration in surgery of malignant neoplasms of the paranasal sinuses. The value of preoperative computed tomography. Arch Otolaryngol Head Neck Surg (1989) 0.92
Assessment of mandibular invasion of squamous cell carcinoma by various modes of imaging: constructing a diagnostic algorithm. Int J Oral Maxillofac Surg (2008) 0.92
Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population. Oral Dis (2007) 0.91
Going back to the roots: effective utilisation of HLA typing information for bone marrow registries requires full knowledge of the DNA sequences of the oligonucleotide reagents used in the testing. Tissue Antigens (2000) 0.91
Epstein-Barr virus in the sublabial salivary gland in Sjögren's syndrome. Am J Clin Pathol (1989) 0.91
Health risks associated with inhaled nasal toxicants. Crit Rev Toxicol (2001) 0.90
Review article. The rat incisor in toxicologic pathology. Toxicol Pathol (1996) 0.89
Acute humoral rejection after heart transplantation. Transplantation (1988) 0.89
Primary B-cell malignant lymphoma of the maxilla with a sarcomatous pattern and multilobated nuclei. Cancer (1984) 0.89
Endomyocardial biopsies after heart transplantation. The presence of immunoglobulin/immune complex deposits. Transplantation (1989) 0.89
A new and highly sensitive immunohistologic diagnostic criterion for Sjögren's syndrome. Arthritis Rheum (1989) 0.88
Localized infantile myofibromatosis. Report of a case originating in the mandible. J Maxillofac Surg (1984) 0.88
The natural course of an ossifying fibroma. A case report. Int J Oral Maxillofac Surg (1999) 0.88
The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer (2000) 0.87
Sclerosing polycystic adenosis: a case report. B-ENT (2006) 0.87
Neurofibromatosis presenting with a cherubism phenotype. Eur J Pediatr (2006) 0.86
Ki-67 and p53 in T2 laryngeal cancer. Laryngoscope (1998) 0.86
CD8 T cell activation after intravenous administration of CD3 x CD19 bispecific antibody in patients with non-Hodgkin lymphoma. Cancer Immunol Immunother (1995) 0.86
Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol (1998) 0.86
T cell receptor V beta variable gene family expression in human peripheral blood lymphocytes at the mRNA and membrane protein level. Clin Exp Immunol (1992) 0.86
Clinical and immunological significance of HLA-E in stem cell transplantation and cancer. Tissue Antigens (2014) 0.86
An image analysis study on nuclear morphology in metastasized and non-metastasized squamous cell carcinomas of the tongue. J Pathol (1998) 0.86
Myoepithelial carcinoma (malignant myoepithelioma): first report of an occurrence in the maxillary sinus. Histopathology (1998) 0.85
Carcinogenic response of the nasal cavity to inhaled chemical mixtures. Mutat Res (1997) 0.85
Regional odontodysplasia in epidermal nevus syndrome. J Oral Pathol (1985) 0.85
Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab Invest (1999) 0.84
Management of renal cell carcinoma in von Hippel-Lindau disease. Eur J Clin Invest (1999) 0.84
Prognostic factors in localised prostate cancer with emphasis on the application of molecular techniques. Eur Urol (2002) 0.84
Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med (1998) 0.84
An improved, sensitive, non-radioactive in situ hybridization method for the detection of cytokine mRNAs. APMIS (1995) 0.84
Immunohistochemical demonstration of bcl-2 protein in human tooth germs. Arch Oral Biol (1994) 0.84
Long-lived Th2 clones specific for seasonal and perennial allergens can be detected in blood and skin by their TCR-hypervariable regions. J Immunol (1998) 0.84
[Man with cherubism]. Ned Tijdschr Geneeskd (2000) 0.84
Role of human leucocyte antigen DQ in the presentation of T cell epitopes in the major cow's milk allergen alphas1-casein. Int Arch Allergy Immunol (2007) 0.83
Central fibroma of the jaw, odontogenic or desmoplastic. Oral Surg Oral Med Oral Pathol (1983) 0.83
Adhesion molecule expression on skin endothelia in atopic dermatitis: effects of TNF-alpha and IL-4. J Allergy Clin Immunol (1998) 0.83
Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients. Bone Marrow Transplant (1992) 0.83
Immunocytochemical demonstration of intermediate filaments in a granular cell ameloblastoma. J Oral Pathol (1984) 0.83
T cells in cardiac allograft vasculopathy are skewed to memory Th-1 cells in the presence of a distinct Th-2 population. Am J Transplant (2008) 0.82
Clear-cell chondrosarcoma of the maxilla: report of a case. Oral Surg Oral Med Oral Pathol (1980) 0.82
p53 overexpression in oral mucosa in relation to smoking. J Pathol (1999) 0.82
A peculiar complication in Le Fort I osteotomy. J Craniomaxillofac Surg (1988) 0.82
Intra-arterial embolization of head-and-neck cancer with radioactive holmium-166 poly(L-lactic acid) microspheres: an experimental study in rabbits. Int J Oral Maxillofac Surg (2001) 0.82
T cell apoptosis in human heart allografts: association with lack of co-stimulation? Am J Pathol (1998) 0.81
Sensitive detection of p53 mutation: analysis by direct sequencing and multisequence analysis. Cancer Detect Prev (2001) 0.81
The VX2 carcinoma in the rabbit auricle as an experimental model for intra-arterial embolization of head and neck squamous cell carcinoma with dextran microspheres. Lab Anim (1999) 0.81
No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation. Tissue Antigens (2001) 0.81
Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells. Bone Marrow Transplant (1998) 0.81
The growth characteristics of multilocular ameloblastomas. A histological investigation with some inferences with regard to operative procedures. J Maxillofac Surg (1985) 0.81
Chromosome instability predicts the progression of premalignant oral lesions. Oral Oncol (2013) 0.81
Expression of activation antigens on thymocytes in the 'common thymocyte' stage of differentiation. Thymus (1989) 0.81